BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6249196)

  • 1. 2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent.
    Lopez C; Watanabe KA; Fox JJ
    Antimicrob Agents Chemother; 1980 May; 17(5):803-6. PubMed ID: 6249196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic competition studies of 2'-fluoro-5-iodo-1-beta-d-arabinofuranosylcytosine in vero cells and herpes simplex type 1-infected vero cells.
    Chou TC; Lopez C; Colacino JM; Feinberg A; Watanabe KA; Fox JJ; Philips FS
    Mol Pharmacol; 1984 Nov; 26(3):587-93. PubMed ID: 6092904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl-5-iodocytosine against human cytomegalovirus in human skin fibroblasts.
    Colacino JM; Lopez C
    Antimicrob Agents Chemother; 1985 Aug; 28(2):252-8. PubMed ID: 3010842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2.
    Schinazi RF; Fox JJ; Watanabe KA; Nahmias AJ
    Antimicrob Agents Chemother; 1986 Jan; 29(1):77-84. PubMed ID: 3015003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymology and pathogenicity in mice of a herpes simplex virus type 1 mutant resistant to 2'-fluoro-2'-deoxy-1-beta-D-arabinofuranosyl-5-iodocytosine.
    Colacino J; Brownridge E; Greenberg N; Lopez C
    Antimicrob Agents Chemother; 1986 May; 29(5):877-82. PubMed ID: 3015008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mammalian cell line designed to test the mutagenic activity of anti-herpes nucleosides.
    Pizer LI; Mitchell DH; Bentele B; Betz JL
    Int J Cancer; 1987 Jul; 40(1):114-21. PubMed ID: 3036717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro metabolism of 1-beta-D-arabinofuranosylcytosine and 1-beta-2'-fluoroarabino-5-iodocytosine in normal and herpes simplex type 1 virus-infected cells.
    Kreis W; Damin L; Colacino J; Lopez C
    Biochem Pharmacol; 1982 Mar; 31(5):767-73. PubMed ID: 7082345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the antiherpetic activity of 2'-fluoro-5-iodo-ara-C in rabbit eyes and cell cultures.
    Trousdale MD; Nesburn AB; Watanabe KA; Fox JJ
    Invest Ophthalmol Vis Sci; 1981 Dec; 21(6):826-32. PubMed ID: 6273355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of antiherpesviral thymidine analogs against varicella-zoster virus.
    Machida H; Kuninaka A; Yoshino H
    Antimicrob Agents Chemother; 1982 Feb; 21(2):358-61. PubMed ID: 6280604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis.
    Gephart JF; Lerner AM
    Antimicrob Agents Chemother; 1981 Jan; 19(1):170-8. PubMed ID: 6166244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of viral thymidine kinase inhibitor and its effect on deoxynucleotide metabolism in cells infected with herpes simplex virus.
    Nutter LM; Grill SP; Dutschman GE; Sharma RA; Bobek M; Cheng YC
    Antimicrob Agents Chemother; 1987 Mar; 31(3):368-74. PubMed ID: 3034143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and selectivity of some nucleoside analogs as anti-human cytomegalovirus agents.
    Colacino JM; Lopez C
    Antimicrob Agents Chemother; 1983 Oct; 24(4):505-8. PubMed ID: 6316843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir.
    McLaren C; Chen MS; Ghazzouli I; Saral R; Burns WH
    Antimicrob Agents Chemother; 1985 Dec; 28(6):740-4. PubMed ID: 3002245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of herpesvirus deoxyribonucleic acid synthesis by acycloguanosine, 2'-fluoro-5-iodo-aracytosine, and (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Larsson A; Oberg B
    Antimicrob Agents Chemother; 1981 May; 19(5):927-9. PubMed ID: 6271053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleosides. 139. Synthesis and anticytomegalovirus and antiherpes simplex virus activity of 5'-modified analogues of 2'-fluoroarabinosylpyrimidine nucleosides.
    Harada K; Matulic-Adamic J; Price RW; Schinazi RF; Watanabe KA; Fox JJ
    J Med Chem; 1987 Jan; 30(1):226-9. PubMed ID: 3027334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative anti-herpesvirus activities of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, acyclovir, and two 2'-fluoropyrimidine nucleosides.
    Smee DF; Campbell NL; Matthews TR
    Antiviral Res; 1985 Oct; 5(5):259-67. PubMed ID: 2998275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activity of the 3'-amino derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    De Clercq E; Descamps J; Balzarini J; Fukui T; Allaudeen HS
    Biochem J; 1983 May; 211(2):439-45. PubMed ID: 6307280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of 2'-fluoro-2'-deoxycytidine on herpes virus growth.
    Wohlrab F; Jamieson AT; Hay J; Mengel R; Guschlbauer W
    Biochim Biophys Acta; 1985 Mar; 824(3):233-42. PubMed ID: 2982405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus.
    De Clercq E; Descamps J; Verhelst G; Walker RT; Jones AS; Torrence PF; Shugar D
    J Infect Dis; 1980 May; 141(5):563-74. PubMed ID: 6246180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2'Fluoro-5-iodo-arabinosyl-cytosine: a new agent for herpes infections in the immunosuppressed patient.
    Donner AL; Leyland-Jones B
    Drug Intell Clin Pharm; 1984 Nov; 18(11):885-8. PubMed ID: 6094133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.